Next Article in Journal
Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age
Next Article in Special Issue
Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA
Previous Article in Journal
Bioinformatics Designing and Molecular Modelling of a Universal mRNA Vaccine for SARS-CoV-2 Infection
Previous Article in Special Issue
Assessment of Perceived Health Status and Access to Health Service during the COVID-19 Pandemic: Cross-Sectional Survey in Italy
 
 
Article

Article Versions Notes

Vaccines 2022, 10(12), 2106; https://doi.org/10.3390/vaccines10122106
Action Date Notes Link
article xml file uploaded 9 December 2022 11:52 CET Original file -
article xml uploaded. 9 December 2022 11:52 CET Update -
article pdf uploaded. 9 December 2022 11:52 CET Version of Record https://www.mdpi.com/2076-393X/10/12/2106/pdf-vor
article html file updated 9 December 2022 11:54 CET Original file -
article xml file uploaded 13 December 2022 10:48 CET Update -
article xml uploaded. 13 December 2022 10:48 CET Update -
article pdf uploaded. 13 December 2022 10:48 CET Updated version of record https://www.mdpi.com/2076-393X/10/12/2106/pdf-vor
article html file updated 13 December 2022 10:49 CET Update -
article xml file uploaded 20 December 2022 07:46 CET Update -
article xml uploaded. 20 December 2022 07:46 CET Update https://www.mdpi.com/2076-393X/10/12/2106/xml
article pdf uploaded. 20 December 2022 07:46 CET Updated version of record https://www.mdpi.com/2076-393X/10/12/2106/pdf
article html file updated 20 December 2022 07:48 CET Update -
article html file updated 4 March 2023 20:28 CET Update https://www.mdpi.com/2076-393X/10/12/2106/html
Back to TopTop